Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
07/29/14 Galectin Therapeutics (GALT) GR-MD-02 for Non-alcoholic Steatohepatitis (NASH) Subscribers Only Subscribers Only     Subscribers Only
07/29/14 Biogen IDEC (BIIB) Eloctate for Hemophilia A Subscribers Only Subscribers Only     Subscribers Only
07/29/14 Roche (ROG:VX) Gazyva for Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL Subscribers Only Subscribers Only     Subscribers Only
07/29/14 Bristol-Myers Squibb (BMY) Eliquis for Venous Thromboembolism (VTE) Subscribers Only Subscribers Only     Subscribers Only
07/29/14 Adamis Pharmaceuticals (ADMP) Epinephrine PFS for Anaphylaxis Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
07/29/14 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
Now - 07/30/14 Subscribers Only Subscribers Only Regulatory - Approval Decision (Japan)
Now - 07/30/14 Subscribers Only Subscribers Only Trial Data - Top-Line Results
Now - 07/30/14 Subscribers Only Subscribers Only Trial Announcement - Initiation
Now - 07/30/14 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)